Amplification of steroid-mediated SP-B expression by physiological levels of caffeine

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 306, Issue 1, 2014, Pages

  Fehrholz, Markus ^a   Hütten, Matthias ^b,c   Kramer, Boris W ^b   Speer, Christian P ^a   Kunzmann, Steffen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Caffeine tolerance; Cathepsin H; Dexamethasone; H441; Napsin A; Pepsinogen C; Sheep

Indexed keywords

CAFFEINE; PEPSINOGEN II; SURFACTANT PROTEIN B;

ANIMAL EXPERIMENT; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LAMELLAR BODY; LUNG FUNCTION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

EID: 84891517901     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00257.2013     Document Type: Article

References (31)

1. Adén U. Methylxanthines during pregnancy and early postnatal life. Hand Exp Pharmacol 200: 373-389, 2011.
2. Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA. Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 293: L259-L271, 2007.
3. Aranda JV, Beharry K, Valencia GB, Natarajan G, Davis J. Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med 23, Suppl 3: 20-23, 2010.
4. Aranda JV, Turmen T, Davis J, Trippenbach T, Grondin D, Zinman R, Watters G. Effect of caffeine on control of breathing in infantile apnea. J Pediatr 103: 975-978, 1983.
5. Bairam A, Blanchard PW, Bureau MA, Laudignon N, Cote A, Aranda JV. Interactive ventilatory effects of two respiratory stimulants, caffeine and doxapram, in newborn lambs. Biol Neonate 61: 201-208, 1992.
6. Ballard PL, Ertsey R, Gonzales LW, Gonzales J. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids. Am J Respir Cell Mol Biol 14: 599-607, 1996.
7. Ballard PL, Lee JW, Fang X, Chapin C, Allen L, Segal MR, Fischer H, Illek B, Gonzales LW, Kolla V, Matthay MA. Regulated gene expression in cultured type II cells of adult human lung. Am J Physiol Lung Cell Mol Physiol 299: L36-L50, 2010.
8. Bersani I, Kunzmann S, Speer CP. Immunomodulatory properties of surfactant preparations. Expert Rev Anti Infect Ther 11: 99-110, 2013.
9. Chavez-Valdez R, Ahlawat R, Wills-Karp M, Nathan A, Ezell T, Gauda EB. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J Pediatr 158: 57-64, 64. e1, 2011.
10. Fehrholz M, Bersani I, Kramer BW, Speer CP, Kunzmann S. Synergistic effect of caffeine and glucocorticoids on expression of surfactant protein B (SP-B) mRNA. PLoS One 7: e51575, 2012.
11. Gavilanes AW, Gantert M, Strackx E, Zimmermann LJ, Seeldrayers S, Vles JS, Kramer BW. Increased EEG delta frequency corresponds to chorioamnionitis-related brain injury. Front Biosci 2: 432-438, 2010.
12. Gerson KD, Foster CD, Zhang P, Zhang Z, Rosenblatt MM, Guttentag SH. Pepsinogen C proteolytic processing of surfactant protein B. J Biol Chem 283: 10330-10338, 2008.
13. Guttentag S. Posttranslational regulation of surfactant protein B expression. Semin Perinatol 32: 367-370, 2008.
14. Horrigan LA, Kelly JP, Connor TJ. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111: 877-892, 2006.
15. Ladenburger A, Seehase M, Kramer BW, Thomas W, Wirbelauer J, Speer CP, Kunzmann S. Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway. Am J Physiol Lung Cell Mol Physiol 299: L578-L584, 2010.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408, 2001.
17. Martin RJ, Abu-Shaweesh JM, Baird TM. Apnoea of prematurity. Paediatr Respir Rev 5, Suppl A: S377-S382, 2004.
18. Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93: 1860-1863, 1994.
19. Perez-Gil JS, Weaver TE. Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 25: 132-141, 2010.
20. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3: CD004454, 2006.
21. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67: 1111-1117, 1981.
22. Schmidt B, Roberts R, Millar D, Kirpalani H. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-lowbirth-weight infants. Neonatology 93: 284-287, 2008.
23. Seehase M, Collins JJP, Kuypers E, Jellema RK, Ophelders DRMG, Ospina OL, Perez-Gil J, Bianco F, Garzia R, Razzetti R, Kramer BW. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. PLoS One 7: e47631, 2012.
24. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 11: 354-362, 2006.
25. Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O, Harms K, Herting E, McClure G, Reid M, Tubman R, Herin P, Noack G, Kok J, Koppe J, van Sonderen L, Laufkötter E, Köhler W, Boenisch H, Albrecht K, Hanssler L, Haim M, Oetomo SB, Okken A, Altfeld PC, Groneck P, Kachel W, Relier J-P, Walti H. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 89: 13-20, 1992.
26. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Halliday HL; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update. Neonatology 97: 402-417, 2010.
27. Vidaeff AC, Ramin SM, Gilstrap LC, Alcorn JL. In vitro quantification of dexamethasone-induced surfactant protein B expression in human lung cells. J Matern Fetal Neonatal Med 15: 155-159, 2004.
28. Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 63: 555-578, 2001.
29. Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Bührer C, Endesfelder S. Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J 41: 966-973, 2013.
30. Whitsett JA, Glasser SW. Regulation of surfactant protein gene transcription. Biochim Biophys Acta 1408: 303-311, 1998.
31. Yang L, Johansson J, Ridsdale R, Willander H, Fitzen M, Akinbi HT, Weaver TE. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol 184: 975-983, 2010.